Concept
Research Network
Canada has the strengths to lead in life sciences. Now will it? - The Globe and Mail / Building on Canada’s advantage
"BMS Canada invests close to $45-million annually in research and development, working with institutes across the country to help build one of Canada’s largest clinical trial networks among major pharmaceutical companies.\n\nAt the end of 2025, the company had 100 active trials across multiple therapeutic areas involving roughly 1,000 patients at nearly 300 sites, ranking among the top five pharmaceutical companies for active trials in Canada. Close to 70 per cent of BMS’s global priority clinical trials are conducted here."
Related Ideas
- National AdvantagesCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Strength meets a structural gap
- Sector ScaleCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Building on Canada’s advantage
- Global LeadershipCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Closing the gap, together
- Policy PrioritiesCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Strength meets a structural gap
- Access GapCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Strength meets a structural gap
- Policy ActionCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Closing the gap, together
- FAST ProgramCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Ontario’s FAST program is proof it can work
- Scaling ApproachesCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Ontario’s FAST program is proof it can work